Literature DB >> 23901401

Cervical total disc replacement C5/6.

Petr Suchomel1, Pavel Barsa.   

Abstract

Mesh:

Year:  2013        PMID: 23901401      PMCID: PMC3676548          DOI: 10.1007/s00586-013-2819-0

Source DB:  PubMed          Journal:  Eur Spine J        ISSN: 0940-6719            Impact factor:   3.134


× No keyword cloud information.
  8 in total

1.  Radiculopathy and myelopathy at segments adjacent to the site of a previous anterior cervical arthrodesis.

Authors:  A S Hilibrand; G D Carlson; M A Palumbo; P K Jones; H H Bohlman
Journal:  J Bone Joint Surg Am       Date:  1999-04       Impact factor: 5.284

2.  Assessment of adjacent-segment disease in patients treated with cervical fusion or arthroplasty: a prospective 2-year study.

Authors:  James T Robertson; Stephen M Papadopoulos; Vincent C Traynelis
Journal:  J Neurosurg Spine       Date:  2005-12

3.  The success of anterior cervical arthrodesis adjacent to a previous fusion.

Authors:  A S Hilibrand; J U Yoo; G D Carlson; H H Bohlman
Journal:  Spine (Phila Pa 1976)       Date:  1997-07-15       Impact factor: 3.468

4.  Clinical and radiographic analysis of cervical disc arthroplasty compared with allograft fusion: a randomized controlled clinical trial.

Authors:  Praveen V Mummaneni; J Kenneth Burkus; Regis W Haid; Vincent C Traynelis; Thomas A Zdeblick
Journal:  J Neurosurg Spine       Date:  2007-03

5.  Clinical outcomes of BRYAN cervical disc arthroplasty: a prospective, randomized, controlled, multicenter trial with 24-month follow-up.

Authors:  Rick C Sasso; Joseph D Smucker; Robert J Hacker; John G Heller
Journal:  J Spinal Disord Tech       Date:  2007-10

6.  Long-term results after anterior cervical fusion and osteosynthetic stabilization for fractures and/or dislocations of the cervical spine.

Authors:  J Goffin; J van Loon; F Van Calenbergh; C Plets
Journal:  J Spinal Disord       Date:  1995-12

7.  Results of the prospective, randomized, controlled multicenter Food and Drug Administration investigational device exemption study of the ProDisc-C total disc replacement versus anterior discectomy and fusion for the treatment of 1-level symptomatic cervical disc disease.

Authors:  Daniel Murrey; Michael Janssen; Rick Delamarter; Jeffrey Goldstein; Jack Zigler; Bobby Tay; Bruce Darden
Journal:  Spine J       Date:  2008-09-06       Impact factor: 4.166

8.  Clinical results and development of heterotopic ossification in total cervical disc replacement during a 4-year follow-up.

Authors:  Petr Suchomel; Lubomír Jurák; Vladimír Benes; Radim Brabec; Ondrej Bradác; Shamel Elgawhary
Journal:  Eur Spine J       Date:  2009-12-25       Impact factor: 3.134

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.